Type 2 diabetes mellitus with hyperosmolarity
ICD-10 E11.0 is a billable code used to indicate a diagnosis of type 2 diabetes mellitus with hyperosmolarity.
Type 2 diabetes mellitus with hyperosmolarity is a serious metabolic condition characterized by elevated blood glucose levels, leading to hyperosmolar hyperglycemic state (HHS). This condition typically arises in individuals with poorly controlled diabetes, often precipitated by infections, dehydration, or other stressors. Patients may present with severe hyperglycemia, often exceeding 600 mg/dL, and exhibit symptoms such as extreme thirst, frequent urination, and altered mental status. Unlike diabetic ketoacidosis (DKA), HHS is more common in type 2 diabetes and is marked by the absence of significant ketone production. Management involves aggressive rehydration, insulin therapy to lower blood glucose levels, and addressing any underlying causes. Regular monitoring of HbA1c levels is crucial for assessing long-term glycemic control, with target levels typically below 7% for most adults. Failure to manage this condition can lead to severe complications, including renal failure, seizures, and even coma.
Detailed records of blood glucose monitoring, HbA1c levels, and treatment plans.
Patients presenting with uncontrolled diabetes, frequent hospitalizations due to hyperglycemia.
Endocrinologists must ensure comprehensive documentation of all diabetes-related complications.
Immediate assessment of blood glucose levels, vital signs, and mental status.
Patients presenting with altered mental status and severe hyperglycemia.
Emergency physicians should document the acute management steps taken to stabilize the patient.
Used when a patient with E11.0 presents to the emergency department.
Document the patient's presenting symptoms, vital signs, and treatment provided.
Emergency physicians should ensure all acute interventions are documented.
Key symptoms include extreme thirst, frequent urination, dry skin, confusion, and altered mental status.
Management involves aggressive rehydration, insulin therapy, and monitoring for complications.
